Equities
Health CareHealth Care Providers
  • Price (USD)349.50
  • Today's Change1.12 / 0.32%
  • Shares traded42.00
  • 1 Year change-31.06%
  • Beta0.4537
Data delayed at least 15 minutes, as of Mar 27 2024 20:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.

  • Revenue in USD (TTM)106.37bn
  • Net income in USD2.49bn
  • Incorporated1964
  • Employees67.60k
  • Location
    Humana Inc500 W Main StLOUISVILLE 40202United StatesUSA
  • Phone+1 (502) 580-1000
  • Fax+1 (302) 655-5049
  • Websitehttp://www.humana.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chemed Corp2.26bn272.51m9.74bn15.09k35.958.7429.214.3017.9217.92148.9973.691.46131.5914.11150,090.6017.5219.5321.7924.6435.2834.6012.0312.601.57--0.0148.156.064.909.175.801.466.10
Tenet Healthcare Corp20.55bn611.00m10.49bn78.14k17.986.524.810.51035.835.83196.0016.090.74098.806.58262,950.404.733.616.755.0982.5382.976.384.951.424.150.73150.007.172.3349.0241.424.01--
Davita Inc12.14bn691.54m12.00bn70.00k18.4711.517.050.98867.417.41130.2911.890.717965.975.89173,430.705.665.627.557.4531.4730.707.888.331.134.770.7536--4.571.2626.442.33-10.47--
Universal Health Services, Inc.14.28bn717.49m12.22bn73.35k17.741.999.500.855910.2510.25203.6691.531.04--6.71194,710.005.246.446.147.63----5.046.551.295.690.4426.066.595.806.32-1.471.1714.87
Quest Diagnostics Inc9.25bn850.00m14.51bn40.00k17.512.3110.981.577.497.4981.5256.820.688932.397.69231,300.006.579.287.5810.8133.1436.649.5312.971.208.470.423425.07-6.384.20-9.773.401.277.43
Laboratory Corporation of Amerc Holdings12.16bn379.20m18.21bn67.00k51.412.3119.021.504.214.65139.1193.860.659518.614.75181,516.402.066.272.497.3727.6732.333.139.511.025.890.3944--2.511.42-62.16-16.403.62--
Molina Healthcare Inc34.07bn1.09bn24.52bn18.00k22.265.7619.430.719818.8118.81587.2072.672.50--12.611,892,889.008.027.6217.9116.8015.8615.993.203.04--14.810.36140.006.5612.5237.759.0622.87--
Centene Corp154.00bn2.70bn41.91bn67.70k15.951.6210.440.27214.914.91282.1848.351.91--10.692,274,727.003.342.585.623.9911.2411.591.751.37--4.700.40720.006.5420.70124.7924.593.43--
Humana Inc106.37bn2.49bn42.13bn67.60k17.632.6312.160.396119.8319.83855.93133.052.36----1,573,580.005.657.57--------2.393.35--9.250.416712.5414.5413.33-11.307.6510.4113.25
HCA Healthcare Inc64.97bn5.24bn87.73bn220.00k17.47--9.571.3518.9818.98235.03-6.681.204.846.89295,309.1011.2111.9915.1215.7584.7684.109.3810.171.025.020.973910.547.866.84-7.1110.135.8311.38
Cigna Group195.27bn5.16bn106.22bn72.50k20.902.3012.640.54417.3917.39657.71158.031.3232.6411.182,693,310.003.624.095.205.5512.8913.982.753.610.65085.930.400213.698.1732.15-22.9714.4224.40161.81
Data as of Mar 27 2024. Currency figures normalised to Humana Inc's reporting currency: US Dollar USD

Institutional shareholders

36.03%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202310.64m8.82%
BlackRock Fund Advisorsas of 31 Dec 20236.24m5.17%
SSgA Funds Management, Inc.as of 31 Dec 20235.83m4.84%
Wellington Management Co. LLPas of 31 Dec 20235.36m4.45%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 20233.73m3.09%
Fidelity Management & Research Co. LLCas of 31 Dec 20233.48m2.88%
Geode Capital Management LLCas of 31 Dec 20232.38m1.97%
Capital Research & Management Co. (World Investors)as of 31 Dec 20232.33m1.93%
Capital Research & Management Co. (Global Investors)as of 31 Dec 20232.00m1.66%
Norges Bank Investment Managementas of 31 Dec 20231.48m1.23%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.